Drug intelligence / Profile preview

lacosamide + lamotrigine + methylprednisolone + perampanel

Development stage
Unknown
Lead developer
UCB
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

This is a combination of four distinct pharmaceutical medications: lacosamide, lamotrigine, methylprednisolone, and perampanel, each with their own properties and uses. ### Lacosamide (Vimpat) Lacosamide is an anticonvulsant medication with a unique mode of action. It's used to treat partial-onset seizures (focal seizures) and primary generalized tonic-clonic seizures. It can be taken alone or in combination with other antiepileptic drugs. Lacosamide is available as both brand-name (Vimpat) and generic versions and is classified as a schedule V controlled substance. ### Lamotrigine (Lamictal) Lamotrigine is a phenyltriazine antiepileptic drug used to treat certain types of epilepsy and bipolar I disorder. It's available in immediate-release and extended-release formulations. The immediate-release version can also be used for bipolar disorder. Lamotrigine works by stabilizing neuronal membranes and inhibiting the release of excitatory neurotransmitters. ### Methylprednisolone (Medrol) Methylprednisolone is a corticosteroid similar to a natural hormone produced by the adrenal glands. It's used to treat various conditions by reducing inflammation and modifying the body's immune response. These conditions include endocrine disorders, rheumatic disorders, collagen diseases, skin diseases, severe allergies, eye problems, gastrointestinal problems, respiratory problems, blood disorders, neoplastic diseases, multiple sclerosis flare-ups, and certain infections. ### Perampanel Perampanel is an antiepileptic medication. Specific information about its mechanism was not provided in the search results. ### Drug Interactions The search results indicate some important interactions between these medications: - Lacosamide and lamotrigine together can increase the risk of an irregular heart rhythm that may be serious. - A study found that the combination of lacosamide with lamotrigine showed synergistic anticonvulsant effects in a 6-Hz-induced seizure model in mice, without enhanced adverse effects on motor coordination. - However, another study found that the three-drug combination of lacosamide, lamotrigine, and valproate showed sub-additive (antagonistic) interaction in a maximal electroshock-induced seizures model in mice. The specific four-drug combination of lacosamide, lamotrigine, methylprednisolone, and perampanel was not directly addressed in the search results, and the interactions among all four drugs together would need further investigation. Given the potential for serious interactions between just two of these medications (lacosamide and lamotrigine), the four-drug combination would require careful medical supervision and monitoring for adverse effects.

02

Targets

CRMP2 (Collapsin response mediator protein 2)GR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)AMPAR (AMPA receptor)

Beyond the preview

Go deeper on lacosamide + lamotrigine + methylprednisolone + perampanel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lacosamide + lamotrigine + methylprednisolone + perampanel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call